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Evidence-based cardiovascular care
Family physicians’ views of obstacles and opportunities
Wayne Putnam, MD, FCFP  Peter L. Twohig, PHD Frederick I. Burge, MD, FCFP
Lois A. Jackson, PHD Jafna L. Cox, MD, FRCPC
ABSTRACT
OBJECTIVE To explore obstacles to and opportunities for applying specifi c lifestyle and pharmacologic recommendations on 
chronic ischemic heart disease.
DESIGN Qualitative study.
SETTING Rural, town, and city settings in Nova Scotia.
PARTICIPANTS Fifty family physicians caring for patients with cardiovascular (CV) disease.
METHOD Nine focus groups were conducted, audiotaped, and transcribed. Seven recommendations had been selected for 
discussion based on their relevance to primary care, strength, and class of supporting evidence. Analysis was guided by 
grounded-theory methodology.
MAIN FINDINGS “Ischemic events” can be powerful motivators for change, whereas the asymptomatic nature of CV risks 
and distant outcomes can form obstacles. Trust built through previous experiences and the opportunity to repeat important 
messages can facilitate application of evidence, but patient-physician relationships can also pose obstacles.
CONCLUSION Physicians can take steps to improve care, but success at reducing CV risks depends upon active involvement of 
many health professionals and community resources. Future guideline implementation should focus on patient-oriented issues, 
such as comorbidity and treatment preferences.
RÉSUMÉ
OBJECTIF Déterminer les facteurs favorables et défavorables à la mise en œuvre de recommandations d’ordre comportemental 
et pharmacologique concernant la maladie coronarienne (MC).
TYPE D’ÉTUDE Étude qualitative.
CONTEXTE Milieu rural et municipalités de petite et moyenne dimensions de Nouvelle Écosse.
PARTICIPANTS Cinquante médecins de famille traitant des patients atteints de maladie coronarienne.
MÉTHODE Neuf groupes de discussion ont été formés et les enregistrements des séances ont ensuite été transcrites. On avait choisi 
sept recommandations en fonction de leur relation avec les soins de première ligne, de leur force et de la catégorie des preuves à 
l’appui. L’analyse des données s’inspirait de la méthodologie dite «grounded-theory».
PRINCIPAUX RÉSULTATS Les manifestations ischémiques sont souvent très effi  caces pour déclencher des changements 
comportementaux, alors que la nature asymptomatique et lointaine du risque de MC est plutôt un obstacle. La mise en 
œuvre des recommandations est favorisée par l’établissement antérieure d’un lien de confi ance et la répétition des consignes 
importantes, mais la relation médecin-patient peut aussi constituer un obstacle.  
CONCLUSION L’amélioration des soins est du ressort du médecin, mais la réduction du risque de MC ne peut être atteinte qu’avec la 
collaboration de plusieurs professionnels de la santé et le soutien des ressources communautaires. À l’avenir, la mise en œuvre des 
directives devrait être centrée sur des facteurs propres au patient, tels la comorbidité et les préférences thérapeutiques.
This article has been peer reviewed.
Cet article a fait l’objet d’une évaluation externe.
Can Fam Physician 2004;50:1397-1405.
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ardiovascular (CV) disease is an impor-
tant cause of morbidity and mortality,1-3
and a large volume of evidence sup-
ports appropriate care. The Canadian Medical 
Association Infobase contains 97 guidelines in 
cardiology for 1999-2001.4 Yet questions remain 
regarding implementation of recommendations 
from guidelines generally,5-12 and ample quantita-
tive data point to “care gaps.”13-17
The publication of a Canadian consensus 
statement on chronic ischemic heart disease18
provided us with the opportunity to explore 
the contexts or situations in which FPs from 
rural, town, and urban settings could or could 
not readily apply specific recommendations. 
Although we have described a variety of issues 
regarding CV evidence in primary care gener-
ally,19 this paper aims to explore the application 
of seven specific lifestyle and pharmacologic 
recommendations.
Focus groups were selected for this study because 
they allow participants to share their clinical expe-
riences with their peers, and can reveal diff erences 
and similarities within groups. Th ey have been used 
to explore aspects of doctor-patient relationships,20
perceptions of risk,21 and uptake of evidence.19,22
Focus groups have been used successfully with FPs 
and general practitioners.23-25 By building on our 
experience and by conducting focus groups in the 
same geographic setting,22,26 we believed that respon-
dents sharing their experiences with their peers from 
a geographically circumscribed area would reveal a 
range of obstacles to and opportunities for imple-
mentation of evidence-based CV recommendations.
To explore the possibility of community variation, 
we conducted groups in nine areas, including rural, 
town, and urban settings. Following Tudiver and 
Talbot, we believed that “any family physician could 
inform us on the matter.”27 Because many of our set-
tings were quite small, some participants were famil-
iar with one another. While market researchers and 
others have expressed a preference for groups com-
posed of strangers,28-30 the issue of acquaintanceship 
created a favourable group dynamic wherein partici-
pants felt comfortable sharing their experiences.
Nine focus groups were conducted with FPs 
throughout Nova Scotia, three each in rural (popu-
lation < 10 000), town (population 10 000 to 50 000), 
and urban settings (population > 50 000). Eight 
groups involved four to nine participants; one in 
a rural setting involved only two. Criterion sam-
pling31 ensured an appropriate mix of male and 
female participants who were at earlier and later 
stages of their careers. Family physicians were 
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Defi nitions used in qualitative research
Criterion sampling—As noted by Creswell,31 criteria for selecting 
participants for a study are based on such issues as “people representative of 
the culture-sharing group in terms of demographics and the contexts that 
lead to diff erent forms of behaviour.”
Ecological model—The ecological model aims to get beyond the individual 
and psychological lifestyle focus of health education, to more distal 
determinants of health that are beyond the control of individuals (such as 
cultural infl uences, public policy).
Defi nitions from Creswell.31
METHODS
VOL 50: OCTOBER • OCTOBRE 2004 d Canadian Family Physician • Le Médecin de famille canadien 1399
Evidence-based cardiovascular care Research
eligible if they had practised in the community for 
more than 1 year and had enough CV patients in 
their practices to contribute to discussions. Two 
thirds of those approached participated (50 of 76). 
Recruitment details are included in Table 1.19
Seven recommendations were selected for discus-
sion (Table 218) based on their relevance to primary 
care, strength (Grade A or E), and class of supporting 
evidence (class I or II). After a “discussion starter”28
on evidence in CV disease in general, several spe-
cifi c recommendations were then presented to par-
ticipants, and discussion was guided by an interview 
template (available on request). Questions were based 
on the ecological model of social organization32 and 
explored very broad considerations (eg, cultural 
issues), a variety of local factors including available 
community resources, and clinical encounters with 
various patients. Individual focus groups typically dis-
cussed three or four of the recommendations.
Each session was facilitated by the lead inves-
tigator (W.P.) and comoderated by another team 
member (P.T. for eight and F.B. for one), who kept 
fi eld notes. All sessions were audiotaped, and the 
researchers present were debriefed immediately 
after each session to identify major areas of discus-
sion. Transcripts were prepared within 48 hours 
and reviewed. The research team believed that 
no new themes were emerging beyond the eighth 
focus group.
After reading the transcripts independently, two 
team members (W.P. and P.T.) worked together to 
compare and contrast emerging ideas and to orga-
nize them into conceptual categories. The other 
researchers (F.B., L.J., and J.C.) reviewed transcripts 
independently and critiqued and confirmed pre-
liminary categories. Disagreements were resolved 
through team discussion. Th e process was repeated 
until the categories were clear; this would enhance 
the trustworthiness of the interpretation. A sin-
gle team member (P.T.) then coded the transcripts 
using QSR NUD.IST, version 4.33 Other team 
members checked the coding carefully to ensure 
Table 1. Recruitment of Nova Scotia physicians for nine focus 
groups on use of evidence-based medicine in primary care
LOCATION NO. INVITED NO. ELIGIBLE*




1     7    4          4 (100)
2     4    4          2 (50)
3     8    4          4 (100)
TOTAL   19  12        10 (83)
SEMIURBAN (TOWNS)
1   22  12          8 (66)
2   19  11          8 (73)
3   14  10          6 (60)
TOTAL   55  33        22 (66)
URBAN
1 and 2†   26  23        14 (61)
3   25     8          4 (50)
TOTAL   51   31       18 (58)
OVERALL TOTAL 125 76       50 (66)
Reprinted with permission from Putnam et al.19
*Reasons for ineligibility included physician no longer living in the area; physician living and practising 
in the area for less than 1 year; unable to contact physician; scheduling confl ict or physician ill or out 
of town at the time of the focus group; ischemic heart disease a small part of physician’s practice; and 
physician on call.
†These groups were conducted in the same urban setting. Physicians were recruited for either group, 
and attendance was six in location 1 and eight in location 2.
Table 2. Recommendations for patients with chronic ischemic 
heart disease 
RECOMMENDATION GRADE* CLASS†
Abstinence from smoking A I
Lowering low-density lipoprotein cholesterol to less 
than 2.6 mmol/L with hepatic hydroxymethylglutaryl 
coenzyme A (HMG-CoA) reductase inhibitor
A II
Angiotensin-converting enzyme inhibitors for patients 
with moderate-to-severe left ventricular dysfunction
A I
β-Blockers after myocardial infarction A I
Short-acting dihydropyridines are dangerous for 
patients with congestive heart failure and should not 
be used
E I
Therapy to reduce blood pressure to less than
140/90 mm Hg
A I
Regular exercise training to reduce angina and 
promote well-being
A I
Adapted from the Canadian Cardiovascular Society 1997 Consensus Conference on the Evaluation and 
Management of Chronic Ischemic Heart Disease.18
*Grade A: evidence suffi  cient for universal use,
Grade B: evidence acceptable for widespread use,
Grade C: evidence insuffi  cient to recommend for or against use,
Grade D: evidence acceptable to recommend against use, and
Grade E: evidence suffi  cient to recommend prohibition.
†Class I: evidence based on at least one prospective randomized controlled trial,
Class II: evidence based on at least one non-randomized cohort comparison or on multicentre case stud-
ies, on chronological series, or on extraordinary results from non-randomized trials,
Class III: expert opinion based upon extensive clinical experience, descriptive studies, or reports of an 
expert committee.
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accuracy and to ensure that the spectrum of expe-
rience was represented.
Our analysis was guided by grounded theory 
methodology.34-37 This approach is excellent for 
understanding complex social realities, such as 
the application of CV recommendations in family 
practice. Specifically, we used an open coding 
strategy, facilitated by use of QSR NUD.IST, ver-
sion 4,33 to identify concepts in our data that were 
then discussed by the research team. We kept notes 
of our team meetings, generated data reports using 
the software, used analytical memos, and docu-
mented our process to create an audit trail. These 
analytical processes enabled the researchers to 
develop and understand physicians’ perceptions of 
the challenge of applying evidence-based CV rec-
ommendations in specific communities.
The Research Ethics Committee of the Queen 
Elizabeth II Health Sciences Centre approved this 
study.
FINDINGS
Barriers to and facilitators of particular recom-
mendations identified by participants are sum-
marized in Table 3. Many responses transcended 
a single recommendation, however; we analyzed 
these broader responses using grounded theory. 
We describe two major themes among data drawn 
from all the settings: how physicians believed 
patients experienced and dealt with disease, and 
ongoing patient-physician relationships.
Patients’ reactions to disease and treatment. 
This first theme includes responses arising from a 
variety of patient characteristics and behaviours. 
Participants reported that an “event,” such as an 
acute myocardial infarction or even the diagno-
sis of ischemic heart disease, is a powerful moti-
vator for patients to change lifestyle or take new 
medications. “You can tell them to stop smoking 
day after day after day after day; as soon as they 
have an event, they stop smoking.… [T]he bigger 
the event, the more they’ll respond.” Participants 
described taking advantage of these opportunities 
for influencing patients’ behaviour. Recognizing 
that they cannot raise some issues too often, an 
event allows them to “strike while the iron’s hot!… 
you don’t do it at every visit because then it’s over-
kill. You can sit there and certainly beat a dead 
horse, and it becomes counterproductive. Then 
they won’t listen to you;… you have to pick the 
time.” Referral for a consultation or invasive pro-
cedure, such as catheterization in a distant centre, 
has a similar effect on some patients.
In contrast, the absence of symptoms for some 
CV risks, such as hyperlipidemia or hyperten-
sion, often limits patients’ motivation to take med-
ications or make difficult lifestyle changes. “If it 
doesn’t hurt, it doesn’t bother them. They can’t see 
it; it doesn’t need treatment.” The fact that the out-
come being prevented is in the distant future and 
that the need for medication could be lifelong, does 
not help. “It’s the person [who] can’t understand 
why they have to take a medication and they don’t 
feel anything from it, or something that might hap-
pen 20 years down the road.” Other patients are 
more willing to begin medications or make other 
changes either because they simply follow their 
physicians’ recommendations or they are inclined 
to take charge of their own health regardless of the 
absence of symptoms.
Many people with CV disease have other health 
problems, and these comorbid conditions have a 
variety of effects. Comorbidity can divert attention 
to issues that seem more pressing at the time. “I 
think one of the challenges of primary care is they 
usually come in with a multitude of other things 
they want you to deal with.… Sometimes it’s easy to 
lose track of a particular problem because they’re 
bringing multiple problems to you.” Family physi-
cians need to deal with and balance various clinical 
issues, and often are unable to focus exclusively on 
one problem (as consultants might).
Cardiovascular disease, alone or with comorbid 
conditions, frequently requires multiple medica-
tions. “You’ve got evidence for this drug, you’ve got 
evidence for another drug. Four or five classes of 
drugs: you’ve got evidence for all of them.” When 
faced with resistance to starting many pills at once, 
often too expensive for patients, FPs might resort 
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Table 3. Recommendation-specifi c responses (full list)
RECOMMENDATION FACILITATORS AND OPPORTUNITIES BARRIERS AND OBSTACLES
Abstinence from smoking • “Readiness” (stage of change)
• Self-reliant personality type  
• “Guilt” in pregnant women
• Concern for health of family members
• Family support
• Physician’s offi  ce a non-smoking environment
• Patient education materials
• Physician’s empathy after relapse
• Marginalization of smokers in society
• Workplace ban on smoking or support for 
   cessation
• Low socioeconomic status
• Degree of addiction
• Epicurean personality type
• Complicated lives some patients lead
• Women’s concern over weight
• Diffi  culty making several lifestyle changes at 
  once, under stress
• Cost of bupropion
• Unhelpful evidence
• Smoking part of culture for some lower 
   socioeconomic groups
Low-density lipoproteins • Fear of another event
• Increased awareness that visits to doctor for 
   prevention are worthwhile
• Nurse in offi  ce to do counseling
• Risk factor tables
• Local specialists setting the standard (ie, goal)
• Nutritionist employed by grocery store
• Lack of motivation in asymptomatic patients
• Outcome distant
• Costs of statins
• Fear of side eff ects
• Real side eff ects in elderly people
• “Last one on” phenomenon
• Inadequate number of nutritionists
• Erratic or nonstandardized blood tests for lipids
Angiotensin-converting enzyme 
inhibitors
• Diabetes as comorbidity
• Symptom relief in congestive heart failure, 
   ie, patients “feel better”
• Minimal side eff ects
• Strong evidence supporting this class of drug
• Cost of some ACE inhibitors
• Impaired renal function
• Need for follow-up blood tests deterrent for some
   elderly and rural patients
β-Blockers • Seen as “protecting” a vital organ
• Protocols on discharge from intensive care unit 
   or hospital
• General knowledge of, and confi dence in, 
   β-blockers in community
• Comorbidity, such as asthma, chronic obstructive
   pulmonary disease, diabetes
• Side eff ects: fatigue, erectile dysfunction
• Frequent dosing of some less expensive β-blockers
Calcium channel blockers (short-acting 
agents contraindicated)
• Awareness from media or Internet of dangers 
  of short-acting calcium channel blockers
• Referral to physician who started drug initially
• Inability in offi  ce setting to identify patients on 
   a particular drug for recall
• Started on drug by consultant (usually tertiary 
   care, at a distance)
Blood pressure control • Fear of strokes
• Comorbidity (eg, ischemic heart disease and 
   other CV risks)
• Risk calculation tables in physicians’ offi  ces
• Easy access to 24-hour monitoring
• Higher level of public awareness about 
   importance of blood pressure control
• Asymptomatic nature of elevated blood pressure
• Side eff ects of treatment
• Cost of medications
Exercise • Desire to lose weight (more important to 
   patients than decreasing CV risk)
• Realistic goals
• Patients’ initiative
• Charting for height and weight in offi  ce
• In-hospital education at time of event
• Community facilities (eg, boardwalks)
• Community programs (eg, walking in schools 
  during winter)
• Harder than taking a pill
• Manual labour occupations
• Physical limitations (arthritis in elderly people)
• Physicians too busy to counsel on exercise
• Evidence less strong than for other risk factors
• Geographic isolation from facilities for rural patients
• Absence of safe place to walk
• Not part of rural culture
• Our climate!
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to a staggered start in contrast to an all-at-once 
strategy in the hospital:
They come [into hospital on] zero pills and come 
home with aspirin, β-blocker, and nitroglycerin; 
[in a week’s time] we add cholesterol [-lowering 
medication], and then we talk about an ACE inhibi-
tor. So it is not swamping; we get [to] the same point 
but maybe over 3 weeks instead of over 72 hours.
In addition to this barrier of polypharmacy, our 
participants also described an antipill sentiment 
among some patients. “[P]eople in general are averse 
to taking medications;… the less medication they 
can take, the better… they feel about themselves.” 
Patients often view complementary or alternative 
medicine differently. “A lot of people say, ‘I’m going 
to try this first. It’s a natural medicine; it’s not harm-
ful, there’s no side effects.’” Side effects were cited 
as another barrier to medication compliance, par-
ticularly for β-blockers (fatigue in women, sexual 
dysfunction in men) and statins (gastrointestinal 
intolerance, especially in elderly people).
Fortunately, physicians have other opportunities. 
Taking a medication often is seen as easier than 
making a lifestyle change, such as beginning regular 
exercise or stopping smoking. “And [patients say] 
‘just give me something that I can take to make this 
better and make this not happen again.’” Patients 
who have symptoms with congestive heart failure 
(CHF) usually feel better while taking angiotensin-
converting enzyme (ACE) inhibitors and so readily 
comply with that recommendation.
Patient-physician ongoing relationships. In con-
trast to the above patient-centred data, the following 
responses dealt with one of the defining character-
istics of family medicine, doctor-patient relation-
ships. Participants were asked about the ways their 
relationships with patients affected the application 
of evidence. Previous treatment “successes” build 
trust that facilitates acceptance of new recommen-
dations. Family physicians can repeat a message 
during subsequent visits or with family members 
if necessary, which also enhances patients’ accep-
tance of evidence. “[E]ven if they only get a third of 
what we tell them, we’re going to see them again, so 
you hope that by repeatedly giving them the same 
message, they’ll get the really important stuff.” “Or 
we would know;… we can talk to their wife or their 
son or their daughter and explain things to them, 
and maybe get them to reinforce it to the patient.”
An important part of the relationship is informa-
tion sharing and decision making. Some patients 
on one end of the spectrum prefer to defer to phy-
sicians’ opinions, and might not even want to hear 
the options for treatment. “My experience here is 
that a significant number of my patients want pater-
nalistic medicine, and they want me to tell them 
what to do;… they are quite distressed by me pre-
senting them options.” Another participant drew a 
distinction between older and younger patients. “I 
find that there’s an age group where… they’d really 
be quite happy if I took a paternalistic approach, 
and I recognize who they are and I’m always try-
ing to gauge it when they come in,… whereas the 
younger ones say, ‘what will happen?’”
Some patients will want to hear the options, 
engage the issues, and make their own decisions 
about the evidence. “They’re either coming in and 
telling you what they read or saw on the Internet 
and [asking] why [you aren’t] doing that and getting 
your hackles all in an uproar. Or they’re coming in… 
looking for a dialogue of equals.” Regardless of the 
type of relationship, physicians in smaller com-
munities felt they knew their patients better. “One 
advantage of a small community is you really know 
the patients. [W]e know the whole family and the 
patients, and they don’t just come and see you just 
for 15 minutes;… you meet them in drug store; you 
meet them [in other settings].
Such familiar relationships can also pose 
obstacles. For example, physicians find it diffi-
cult in some circumstances to be blunt enough 
to make the point, and patients might not take 
the advice seriously. “[H]e hasn’t been listen-
ing to me, because I’m a buddy.” A long-term 
relationship seemed most troublesome to our 
participants when they needed to deal with 
smoking cessation; they hated to nag but knew 
patients needed reminding. “I think a family 
physician is often seen as very supportive of 
VOL 50: OCTOBER • OCTOBRE 2004 d Canadian Family Physician • Le Médecin de famille canadien 1403
Evidence-based cardiovascular care Research 
patients, and I sometimes find it very difficult 
to be [unsupportive] of a behaviour but sup-
portive of the individual.”
DISCUSSION
Participants from rural, town, and urban settings 
raised substantively the same issues about applying 
these seven specific recommendations relevant to 
primary care of patients with chronic ischemic heart 
disease. Although the details differ, participants 
identified an array of opportunities for and obstacles 
to implementation of CV recommendations.
As we have previously argued, applying evi-
dence in primary care is extremely complex.19 Our 
findings reveal two substantial issues that emerge 
from attempts to implement specific CV recom-
mendations. First, FPs must understand and weigh 
patients’ understanding of personal risks and the 
potential for disease. Second, existing relationships 
between FPs and their patients are key to such 
efforts. Moreover, each of these issues can either 
facilitate or limit implementation of or adherence 
to specific CV recommendations. Our findings also 
help characterize “care gaps” by revealing factors 
that influence whether or not a goal or target is 
realistic for specific patients.
Our findings also indicate that any substantial 
success at reducing CV risks will require involve-
ment of many health professionals and support from 
a variety of community resources. Nurses in family 
practices enhance lipid lowering through counsel-
ing. Hospital and community education programs 
play a vital role immediately after an event and in 
the follow-up period. Nutritionists were also identi-
fied as making a substantial contribution, but they 
are in short supply in the communities in our study. 
Specialists play an important role in establishing a 
standard for the medical community, incorporat-
ing evidence (such as the low-density lipoprotein 
cholesterol levels for high-risk patients) into their 
consultations and teaching. The need for consistent 
messages across disciplinary boundaries has recently 
been identified by the Achieving Cardiovascular 
Health in Canada partnership.38
Our study of evidence-based CV recommenda-
tions also reveals potential incongruities between 
medical evidence and public perceptions of risk. 
While strong and plentiful evidence underpins 
current recommendations, patients might not 
intuitively see their importance. The examples of 
asymptomatic patients or of preventing future 
events each reveal particular challenges that could 
require new or different approaches. Individual 
experiences and interpretations of those experi-
ences could overrule other factors. Thus, patients 
who have an event might believe that they are 
more susceptible to future events or complications; 
other factors, such as existing social responsibili-
ties (important relationships, for example), could 
also shape patients’ perceptions of their vulnerabil-
ity. Our findings, therefore, underscore the impor-
tance of belief in perceived susceptibility and belief 
in perceived benefits, two specific aspects of the 
health belief model.39
Patients also put specific recommendations in 
the context of their total health and social situation. 
If they have comorbidity, they must weigh vari-
ous choices, and such complexities fit poorly with 
guidelines developed for a single disease, also a 
concern of the Achieving Cardiovascular Health in 
Canada partnership.38 Family physicians are sensi-
tive to these issues and tailor their practice accord-
ingly. Rather than overwhelm their patients, some 
choose to move more slowly when adding medica-
tions or recommending lifestyle changes. Physicians 
also abandon strict adherence to recommendations 
in order to accommodate their patients’ varied 
interests. In this way, FPs attempt to bridge two of 
the dominant paradigms of contemporary medi-
cine, evidence-based medicine and patient-centred 
medicine.40 What works well for one patient might 
not work for another. A variety of strategies, pur-
sued over time, are necessary, and FPs are ideally 
positioned to match strategies with patients.
The positive aspects of physician-patient rela-
tionships in terms of continuity, prior knowledge 
of patients, prior experience with trust, and con-
fidence in clinical decision making shape how evi-
dence is applied by these FPs. There is evidence 
that continuity for patients over time with the same 
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provider is more likely to increase adherence to 
medication regimens41 and satisfaction with care.42
Our fi ndings are consistent with an hypothesis that 
such continuity allows evidence to be applied better 
when the context of individual patients is known.
Th is study was limited to discussion of selected 
CV recommendations that were well supported by 
evidence. Th e place of recommendations in day-to-
day family practice might be more ambiguous in 
other clinical areas. Another limitation is that our 
study included only FPs. Neither patients nor spe-
cialists were interviewed. Further inquiry is needed 
in other geographic settings, for other clinical con-
ditions, and from patients and other health care 
providers to better explore these ideas.
CONCLUSION
Th is inquiry refocuses attention from the simple 
dissemination of evidence to physicians toward the 
issue of translating evidence in a meaningful way 
for patients. Family physicians must account for 
patients’ health beliefs, preferences, and comor-
bidity, and for both positive and negative eff ects of 
patient-physician relationships on patients’ behav-
iour. Guidelines or consensus statements might 
be more useful for FPs if written with a staged 
approach to implementation, particularly for use 
among patients with comorbidity. When the rela-
tionship is an impediment, as occasionally occurs 
with lifestyle issues, other health professionals have 
a complementary role in counseling and educating 
patients. 
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EDITOR’S KEY POINTS
• This study of family practice in Nova Scotia explored obstacles to and 
opportunities for implementing seven lifestyle and pharmacologic 
recommendations for improving primary care of patients with car-
diovascular disease.
• Among factors that have a positive influence are critical events 
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